These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 32169049

  • 21. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G, Koylan N, Nalbantgil I, Caglar N, Quarti-Trevano F, Makel W, Grassi G, Fici F.
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
    de Beus E, Bots ML, van Zuilen AD, Wetzels JF, Blankestijn PJ, MASTERPLAN Study Group.
    Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
    [Abstract] [Full Text] [Related]

  • 23. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
    Colvin CL, Safford MM, Muntner P, Colantonio LD, Kern LM.
    Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
    [Abstract] [Full Text] [Related]

  • 24. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR, Booth JN, Shimbo D, Lackland DT, Oparil S, Howard G, Safford MM, Muntner P, Calhoun DA.
    J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
    Carey RM, Sakhuja S, Calhoun DA, Whelton PK, Muntner P.
    Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
    [Abstract] [Full Text] [Related]

  • 26. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
    Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, Brecklin CS, Drawz P, Flack JM, Miller ER, Steigerwalt SP, Townsend RR, Weir MR, Wright JT, Rahman M, CRIC Study Investigators.
    Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
    [Abstract] [Full Text] [Related]

  • 27. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data.
    Jafari E, Cooper-DeHoff RM, Effron MB, Hogan WR, McDonough CW.
    Am J Hypertens; 2024 Jan 01; 37(1):60-68. PubMed ID: 37712350
    [Abstract] [Full Text] [Related]

  • 28. Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
    Bakris G, Lin PP, Xu C, Chen C, Ashton V, Singhal M.
    J Clin Hypertens (Greenwich); 2024 May 01; 26(5):500-513. PubMed ID: 38523465
    [Abstract] [Full Text] [Related]

  • 29. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
    Akinyelure OP, Jaeger BC, Safford MM, Oparil S, Carson AP, Sims A, Hannon L, Howard G, Muntner P, Hardy ST.
    J Am Heart Assoc; 2024 May 21; 13(10):e031695. PubMed ID: 38752519
    [Abstract] [Full Text] [Related]

  • 30. Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
    Tanner RM, Shimbo D, Irvin MR, Spruill TM, Bromfield SG, Seals SR, Young BA, Muntner P.
    J Clin Hypertens (Greenwich); 2017 Nov 21; 19(11):1117-1124. PubMed ID: 28921875
    [Abstract] [Full Text] [Related]

  • 31. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
    Chen J, Bundy JD, Hamm LL, Hsu CY, Lash J, Miller ER, Thomas G, Cohen DL, Weir MR, Raj DS, Chen HY, Xie D, Rao P, Wright JT, Rahman M, He J.
    Hypertension; 2019 Apr 21; 73(4):785-793. PubMed ID: 30776971
    [Abstract] [Full Text] [Related]

  • 32. Uncontrolled hypertension among hypertensive patients on treatment in Lupane District, Zimbabwe, 2012.
    Goverwa TP, Masuka N, Tshimanga M, Gombe NT, Takundwa L, Bangure D, Wellington M.
    BMC Res Notes; 2014 Oct 08; 7():703. PubMed ID: 25297796
    [Abstract] [Full Text] [Related]

  • 33. Factors Associated With Treatment and Control of Hypertension in a Healthy Elderly Population Free of Cardiovascular Disease: A Cross-sectional Study.
    Chowdhury EK, Nelson MR, Ernst ME, Margolis KL, Beilin LJ, Johnston CI, Woods RL, Murray AM, Wolfe R, Storey E, Shah RC, Lockery JE, Tonkin AM, Newman AB, Williamson JD, Abhayaratna WP, Stocks NP, Fitzgerald SM, Orchard SG, Trevaks RE, Donnan GA, Grimm R, McNeil JJ, Reid CM, ASPREE Investigator Group.
    Am J Hypertens; 2020 Apr 01; 33(4):350-361. PubMed ID: 31807750
    [Abstract] [Full Text] [Related]

  • 34. Uncontrolled hypertension among patients managed in primary healthcare facilities in Kinshasa, Democratic Republic of the Congo.
    Kika TM, Lepira FB, Kayembe PK, Makulo JR, Sumaili EK, Kintoki EV, M'Buyamba-Kabangu JR.
    Cardiovasc J Afr; 2016 Apr 01; 27(6):361-366. PubMed ID: 27965999
    [Abstract] [Full Text] [Related]

  • 35. Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart Study.
    Shallcross AJ, Butler M, Tanner RM, Bress AP, Muntner P, Shimbo D, Ogedegbe G, Sims M, Spruill TM.
    J Hum Hypertens; 2017 Jul 01; 31(7):474-478. PubMed ID: 28124682
    [Abstract] [Full Text] [Related]

  • 36. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
    Viazzi F, Piscitelli P, Ceriello A, Fioretto P, Giorda C, Guida P, Russo G, De Cosmo S, Pontremoli R, AMD‐Annals Study Group.
    J Am Heart Assoc; 2017 Sep 22; 6(9):. PubMed ID: 28939716
    [Abstract] [Full Text] [Related]

  • 37. Good knowledge about hypertension is linked to better control of hypertension; a multicentre cross sectional study in Karachi, Pakistan.
    Almas A, Godil SS, Lalani S, Samani ZA, Khan AH.
    BMC Res Notes; 2012 Oct 24; 5():579. PubMed ID: 23095492
    [Abstract] [Full Text] [Related]

  • 38. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
    Pedersen E, Garcia BH, Halvorsen KH, Eggen AE, Schirmer H, Waaseth M.
    BMC Cardiovasc Disord; 2021 Jan 21; 21(1):44. PubMed ID: 33478404
    [Abstract] [Full Text] [Related]

  • 39. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
    Mielke J, Trucks-Jansen H, Schurmann C, Kotsis F, Köttgen A, Schneider MP, Eckardt KU, GCKD Investigators, Freitag DF, Eitner F, Becker MS.
    J Hum Hypertens; 2023 May 21; 37(5):345-353. PubMed ID: 35534618
    [Abstract] [Full Text] [Related]

  • 40. Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus.
    Bakris G, Chen C, Campbell AK, Ashton V, Haskell L, Singhal M.
    J Clin Hypertens (Greenwich); 2023 Aug 21; 25(8):737-747. PubMed ID: 37461262
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.